TAG:
clinical lab
At the Epicenter, Northwell’s COVID-19 Lab Data Adds Value
By Joseph Burns | From the Volume XXVII No. 5 – March 30, 2020 Issue
This is an excerpt of a 3,210-word article in the March 30, 2020 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: This intelligence briefing provides a valuable look inside a …
Labs in Italy Moved Fast to Develop COVID-19 Tests
By Robert Michel | From the Volume XXVII No. 5 – March 30, 2020 Issue
Part One in a Series ITALY HAS ONE OF THE WORLD’S SEVEREST OUTBREAKS OF COVID-19 INFECTIONS, based on the number of cases and the mortality rate. In response, clinical laboratories there moved quickly to launch laboratory-developed tests and to increase the volume of COVID-19…
This Coronavirus Outbreak Will Change Lab Industry
By Robert Michel | From the Volume XXVII No. 5 – March 30, 2020 Issue
CEO SUMMARY: COVID-19 is causing a level of global disruption not seen since the influenza outbreak of 1918. This new infectious disease exposes flaws in the strategies and planning of public health officials and governments in the United States and abroad. In this country…
Northwell Lab Team Validates Novel Coronavirus Test on Fast Timeline
This is an excerpt of a 2,375-word article in the March 9, 2020 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Clinical labs are working with haste to develop a no…
Northwell Health Labs Produce Value-Added Outcomes, Growth
By Joseph Burns | From the Volume XXVII No. 3 – February 17, 2020 Issue
>CEO SUMMARY: In 2008, the administration at the Northwell Health system on Long Island considered selling its inpatient and outpatient laboratory services to a commercial laboratory company. In response, the leaders of the Northwell Health Laboratories proposed a plan to s…
Northwell and Memorial Health: A Tale of Two Labs
By R. Lewis Dark | From the Volume XXVII No. 3 – February 17, 2020 Issue
Something very unusual happened in this issue of The Dark Report. We analyzed the entirely opposite fates of two clinical laboratories owned by different healthcare systems. With apologies to author Charles Dickens and his opening sentence in his novel, a Tale of Two Cities, it c…
First EKRA Guilty Plea Involves Lab Kickback
By Joseph Burns | From the Volume XXVII No. 3 – February 17, 2020 Issue
CEO SUMMARY: Federal investigators wasted little time in using the Eliminating Kickbacks in Recovery Act of 2018 (EKRA) to prosecute fraud involving clinical laboratories and providers. The manager of an opioid treatment center in Kentucky pleaded guilty last month to three counts…
Two Collaborations: LabCorp-Thermo Fisher, Roche-Illumina
By Joseph Burns | From the Volume XXVII No. 2 – January 27, 2020 Issue
In deals related to the pursuit of companion diagnostics, two lab companies announced collaboration deals with companies that manufacture gene-sequencing equipment. The deals were announced on consecutive days earlier this month. Financial terms were not disclosed. On Jan. 13, Ro…
NeoGenomics Spends $37M for Human Longevity’s Oncology Division
By Joseph Burns | From the Volume XXVII No. 2 – January 27, 2020 Issue
Once again, Neogenomics, Inc. is using an acquisition to build up its cancer-testing business. In a deal that closed on Jan. 10, the lab company acquired the Oncology Division of Human Longevity, based in San Diego. Neogenomics said it paid $37 million f…
33 Groups Cooperated to Get PAMA-Related LAB Act Passed
By Joseph Burns | From the Volume XXVII No. 2 – January 27, 2020 Issue
>CEO SUMMARY: At the end of 2019, the Laboratory Access for Beneficiaries (LAB) Act became law and addressed two of the three most onerous requirements in the Protecting Access to Medicare Act (PAMA) of 2014. It delays the data-reporting requirements under PAMA, an…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized